Super Bowl, Pfizer
The top barrier to entry for pharma brands considering a marketing play at the Super Bowl is the price point. A 30-second ad ...
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite ...
Pfizer CEO Albert Bourla unpacks the impact of the nomination on 'The Claman Countdown.' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results